Aptevo Therapeutics (APVO) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aptevo Therapeutics is the larger company by market cap ($3.3 million vs $3.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | APVO | PRFX |
|---|---|---|
| Share price | $1.84 | $0.8798 |
| Market cap | $3.33M | $3.08M |
| 1-day change | 0.00% | +0.24% |
| P/E ratio (TTM) | 0.03 | — |
| EPS (TTM) | $66.96 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $33.12 | $7.95 |
| 52-week low | $1.37 | $0.852 |
| Distance from 52-week high | -94.44% | -88.93% |
| Average volume | 93.62K | 298.86K |
| Shares outstanding | 1.81M | 3.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
APVO vs PRFX FAQ
Which is bigger, Aptevo Therapeutics or PRF Technologies?
Aptevo Therapeutics (APVO) is larger, with a market capitalization of $3.33M compared with $3.08M for PRF Technologies (PRFX).
Are Aptevo Therapeutics and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.